-Bloomberg
Neoleukin Therapeutics Highlights Presentation Of Preclinical Data For NL-201 At American Association For Cancer Research
- NL-201 demonstrates antitumor activity in preclinical B-cell lymphoma models -
- NL-201 synergizes with radiation therapy to generate potent, antitumor immunity -
SEATTLE, April 13, 2022 (GLOBE NEWSWIRE) -- Neoleukin